Sopharma AD Company Description

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.

It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana to reduce the stress; and medical devices, such as gauzes, compresses, and dressing.

The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; concentrates for hemodialysis; and prescription medicines, and OTC and veterinary medical products.

In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services.

Further, it is involved in trading of pharmaceuticals; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services.

Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities.

Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.

Sopharma AD

Country	Bulgaria
Founded	1933
Industry	Pharmaceutical Preparations
Employees	5,599
CEO	Ognian Donev

Contact Details

Address: 16, Iliensko Shousse St. Sofia, 1220 Bulgaria
Phone	359 28 13 42 00
Website	sopharmagroup.com

Stock Details

Ticker Symbol	SFA
Exchange	Bulgarian Stock Exchange
Fiscal Year	January - December
Reporting Currency	BGN
SIC Code	2834

Key Executives

Name	Position
Ognian Donev	Chief Executive Officer
Boris Borisov	Chief Financial Officer
Pelagia Viatcheva	Head of Investor Relations